Previous studies have found that cigarette smoking dosage over 30 pack-years was an independent negative predictive factor and meanwhile smoking cessation combined with anti-EGFR treatment like erlotinib seems to be more effective in lung adenocarcinoma with EGFR mutation (39, 40). Here, EGFR is linked to lung adenocarcinoma.